Hellerup

• A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Abrysvo® for Preventing RSV Hospitalizations in Adults Aged 18 Years o … Recruiting
  2024-516600-42-00 6 2024-11-18 RSV-infection
• A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10 … Recruiting
  2023-507353-15-00 5 2024-09-10 idiopathic pulmonary fibrosis (IPF)
• DAPHNE Recruiting
  2024-510746-14-00 6 2024-08-28 Axial Spondyloarthritis
• Palliation of Dyspnea and Cough using Morphine in patients with Fibrotic Interstitial Lung Disease Recruiting
  2023-503700-81-00 6 2024-08-23 Fibrotic Interstitial Lung Disease
• Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study Recruiting
  2024-514900-16-00 6 2024-07-25 Gram-negative Bacteremia
• Azithromycin for treatment of hospitalized children with asthmatic symptoms Recruiting
  2024-512605-29-01 4 2024-07-01 Childhood asthma
• Can patients with atrial fibrillation discontinue anticoagulant therapy after cardiac surgery: The ATLAAC trial Recruiting
  2022-502986-92-00 6 2024-02-27 Atrial fibrillation
• The Colchicine heart failure preserved trial Recruiting
  2023-506207-26-00 5 2024-01-18 Heart failure with preserved ejection fraction (HFpEF)
• The Colchicine and atrial fibrillation trial Recruiting
  2022-500850-40-01 5 2023-05-26 Atrial fibrillation or atrial flutter
• Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) Recruiting
  2023-508105-24-00 5 2021-11-11 COVID-19
• Goal directed fluid removal in critically ill patients with fluid overload Recruiting
  2024-512186-14-00 6 2020-08-24 Fluid overload/fluid accumulation
• A Phase 4 Pragmatic, Randomized Trial to Evaluate the Effectiveness and Safety of mRNA-1273 Variant-Containing Vaccine Formulation Against S … Ended recruitment
  2025-523841-82-00 6 2025-12-11 SARS-CoV-2 infection
• Efficacy and Safety of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MA … Ended recruitment
  2024-515524-36-00 5 2025-05-30 Chronic Weight Management
• Long-term, open-label study of SAR447537 (INBRX-101) in adults with alpha-1 antitrypsin deficiency emphysema Ended recruitment
  2023-508137-14-00 4 2025-03-11 Alpha-1 Antitrypsin Deficiency (AATD) Emphysema
• A research study to look into the long-term effect on weight loss of CagriSema in people with obesity Ended recruitment
  2024-512144-39-00 5 2025-01-22 Obesity
• VAXXAIR TRIAL: In-depth Immunological Analysis of Airway Immunity following Nasal Live Attenuated and Intramuscular Influenza Vaccine A ran … Ended recruitment
  2023-506166-31-01 6 2024-12-23 Influenza
• A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Ended recruitment
  2024-513208-32-00 5 2024-12-16 Chronic Spontaneous Urticaria
• Hidradenitis Suppurativa: Evaluation of lutikizumab in Adult and Adolescent Subjects Ended recruitment
  2024-510730-40-00 5 2024-12-12 Hidradenitis Suppurativa
• Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Ended recruitment
  2023-508235-31-00 5 2024-06-17 Atopic Dermatitis
• Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease Ended recruitment
  2023-504471-25-00 5 2024-03-01 Fibrotic Lung Disease
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc … Ended recruitment
  2022-502779-40-00 5 2023-09-04 Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
• Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes (REC1TE): a randomized, double-blind, placebo-controll … Ended recruitment
  2022-502038-23-00 4 2023-08-25 Type 1 diabetes
• HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation. Ended recruitment
  2022-501939-16-00 5 2023-05-09 Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
• Safety of ibuprofen after major orthopaedic surgeries Ended recruitment
  2022-502502-32-00 11 2023-04-17 Hip and knee arthroplasties

Showing 25–48 of 74 trials